Phase 1 Dose Escalation and Dose Expansion Trial of NP-101 in Patients With Solid Tumors
Phase 1 Dose Escalation and Dose Expansion Trial of NP-101 in Patients With Solid Tumors
Recruiting · NCT06563375 · Registry updated 2026-09-18Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Phase 1 Dose Escalation and Dose Expansion Trial of NP-101 in Patients With Solid Tumors | Solid Tumor | Recruiting | Phase 1 | 2026-09-18 | NCT06563375 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| M.D. Anderson Cancer Center | 1145 |
| Novatek Pharmaceuticals, Inc. | 1 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| MD Anderson Cancer Center | Houston | United States | 589 |